Gnostic and agnostic immunotherapy by tropism-retargeted herpes simplex virus without direct tumor treatment.

J Immunother Cancer · 2025 · PMC12306237 · PMID 40701653

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Figure 1H shows a highly significant reduction in tumor size in Re-IP-treated mice on day 28.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.